Cephalexin is safe for use during pregnancy
Cephalexin is considered safe during pregnancy and is specifically recommended in recent clinical guidelines for pregnant patients requiring systemic antibiotics. The FDA classifies cephalexin as Pregnancy Category B, indicating that animal reproduction studies have shown no harm to the fetus, though adequate controlled studies in pregnant women are limited 1.
Guideline-Based Recommendations
The most recent and highest-quality evidence comes from the 2025 North American clinical practice guidelines for hidradenitis suppurativa, which explicitly states: "In pregnant patients with HS who require systemic antibiotics, we suggest using oral cephalexin as there is evidence it is safe for use in pregnancy" with a conditional recommendation based on moderate-quality evidence 2. This represents the most current guideline-level endorsement of cephalexin safety in pregnancy.
Supporting Evidence from Multiple Clinical Contexts
Intrapartum Use
The CDC's 2010 guidelines for prevention of perinatal Group B Streptococcal disease recommend cefazolin (a related first-generation cephalosporin) as the preferred alternative for penicillin-allergic pregnant women without high-risk allergy features 3. While these guidelines specifically address cefazolin rather than cephalexin, they establish the safety profile of first-generation cephalosporins during pregnancy and labor.
Clinical Trial Data
Multiple clinical studies support cephalexin safety:
- A large population-based case-control study (1980-1996) involving 22,865 pregnant women found no detectable teratogenic risk from cephalosporin treatment, particularly oral cephalexin, during pregnancy 4
- A 1990 prospective randomized trial demonstrated that oral cephalexin (500 mg every 6 hours) was both safe and effective for treating acute pyelonephritis in pregnancy, with 91.4% successful therapy rates 5
- A 1995 randomized controlled trial used oral cephalexin as part of the treatment protocol for pyelonephritis in pregnancy with no adverse fetal outcomes 6
- Studies from 1985 and 1994 confirmed cephalexin safety for treating bacteriuria during pregnancy 7, 8
FDA Drug Label Information
The official FDA labeling confirms:
- Pregnancy Category B classification
- Animal studies at 0.6 to 1.5 times the maximum human dose showed no harm to the fetus
- The label appropriately notes that "adequate and well-controlled studies in pregnant women" are lacking, but states the drug "should be used during pregnancy only if clearly needed" 1
This standard FDA language reflects regulatory caution rather than evidence of harm.
Practical Considerations
When to Use Cephalexin in Pregnancy
- Urinary tract infections (including pyelonephritis and bacteriuria)
- Skin and soft tissue infections requiring systemic antibiotics
- As an alternative to amoxicillin when indicated
- In patients with non-severe penicillin allergies (without history of anaphylaxis)
Dosing
Standard adult dosing (500 mg every 6-8 hours) has been safely used throughout pregnancy in clinical trials 5, 6.
Breastfeeding
Cephalexin is excreted in breast milk but reaches only low levels (maximum 4 mcg/mL at 4 hours post-dose, disappearing by 8 hours). Caution should be exercised but breastfeeding is generally compatible with cephalexin use 1.
Important Caveats
- Avoid in patients with severe penicillin/cephalosporin allergies (history of anaphylaxis, angioedema, respiratory distress) 3
- Monitor for Clostridioides difficile infection as with any antibiotic
- Consider renal function in dose selection, particularly in patients with impaired renal function 1
- The 2025 guidelines note moderate-quality evidence for the safety recommendation, reflecting the inherent limitations of pregnancy drug studies 2
Bottom line: Cephalexin has decades of safe use in pregnancy across multiple clinical contexts, with no evidence of teratogenicity in either animal studies or large human cohorts, and is explicitly recommended in current clinical guidelines.